Involvement of transforming growth factor-β and its receptors in the pathogenesis of diabetic nephropathy

Ziyadeh, Fuad N.; Dong Cheol Han
September 1997
Kidney International Supplement;Sep1997, Issue 60, pS-7
Academic Journal
Examines the involvement of transforming growth factor-β (TGF-β) and its receptors in the pathogenesis of diabetic nephropathy. Secretion of TGF-β as latent complexes; Regulation of cell proliferation; Accumulation of extracellular matrix proteins.


Related Articles

  • Renoprotective Effects of Metformin. Takiyama, Yumi; Honjyo, Jun; Makino, Yuichi; Isoe, Tsubasa; Haneda, Masakazu // Diabetes;Jun2007 Supplement 1, Vol. 56, pA603 

    The biguanide metformin has been used for treating insulin resistance and type 2 diabetes. Moreover, the UK prospective diabetes study (UKPDS) showed that metformin could reduce macrovascular morbility and mortality, suggesting anti-atherogenic and anti-inflammatory effects of metformin....

  • Contribution of Rho/Rho-Kinase Pathway to the Development of Renal Injury in Insulin-Resistant Rats. Gojo, Atsushi; Utsunomiya, Kazunori; Yokota, Tamotsu; Ishizawa, Shou; Kanazawa, Yasushi; Kurata, Hideaki; Tajima, Naoko // Diabetes;Jun2007 Supplement 1, Vol. 56, pA197 

    Insulin resistance plays an important role in the pathogenesis of cardiovascular disease. Recent investigations demonstrated that microalbuminuria is closely related to insulin resistance and predicts risk of mortality from cardiovascular disease in non-diabetic subjects. These findings indicate...

  • Evidence for a Role of Transforming Growth Factor (TGF)-β1 in the Induction of Postglomerular Albuminuria in Diabetic Nephropathy. Russo, Leileata M.; del Re, Elisabetta; Brown, Dennis; Lin, Herbert Y. // Diabetes;Feb2007, Vol. 56 Issue 2, p380 

    Transforming growth factor-β (TGF-β) has previously been implicated in the progression of diabetic nephropathy, including the onset of fibrosis and albuminuria. Here we report for the first time the use of a high-affinity TGF-β1 binding molecule, the soluble human TGF-β type II...

  • Transforming Growth Factor-Beta and the Kidney: What We Know and What We Can Do? Hai-Chun Yang; Yiqin Zuo; Fogo, Agnes B. // Current Enzyme Inhibition;Jul2010, Vol. 6 Issue 2, p87 

    Transforming growth factor-� (TGF-�) and its receptors are expressed in the kidney. The effects of TGF-� are mainly through activation of Smad pathways. In different pathophysiological situations such as development, immunomodulation, fibrosis and cell response, TGF-�...

  • Arkadia enhances nodal-related signalling to induce mesendoderm. Niederlander, Christiane; Walsh, James J.; Episkopou, Vasso; Jones, C. Michael // Nature;4/12/2001, Vol. 410 Issue 6830, p830 

    Presents a study to investigate the function of Arkadia and its role in establishing Spemann's organizer. How the nuclear protein Arkadia specifically potentiates the mesendoderm-inducing activity of a subset of transforming growth factor (TGF)-beta family members; Identification of Arkadia as...

  • The complex world of kidney microRNAs. Kasinath, Balakuntalam S.; Feliers, Denis // Kidney International;Aug2011, Vol. 80 Issue 4, p334 

    MicroRNAs are short noncoding RNAs that usually reduce translation of messenger RNAs. Changes in microRNA-192 (miR-192) are reported in states of renal fibrosis. New evidence supports a role for miR-192 and its target miR-200b/c in transforming growth factor-β1 regulation of its own...

  • Renal TGF-Beta Not Uniquely Elevated in HIV-Associated Renal Diseases.  // Kidney;Mar/Apr98, Vol. 7 Issue 2, p62 

    Discusses the abstract of the article 'Renal TGF-beta in HIV-associated kidney diseases,' by I. Bodi, P.L. Kimmel et al, published in the 1997 issue of the 'Kidney International' journal.

  • Transforming growth factor-Î’[sub1] hyperexpression in African American end-stage renal disease patients. Suthanthiran, Manikkam; Khanna, Ashwani; Cukran, David; Adhikarla, Rohini; Sharma, Vijay K.; Singh, Tejinder; August, Phyllis // Kidney International;Mar1998, Vol. 53 Issue 3, p639 

    Focuses on the effects of transforming growth factor-Beta1 hyperexpression in African-American renal disease patients. Identification of remediable causes of renal diseases in African-American; Correlation of the renal fibrosis failure in the dominant feature of End-stage renal disease(ESRD);...

  • Transforming growth factor beta and progression of renal disease. August, Phyllis; Suthanthiran, Manikkam // Kidney International Supplement;Nov2003, Issue 87, p99 

    Transforming growth factor beta and progression of renal disease. End-stage renal disease (ESRD) is more frequent in African Americans compared to whites. Many factors may be responsible, including genetic differences, increased prevalence of risk factors, and socioeconomic factors; however, to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics